Barclays Maintains Equal-Weight Rating on Insulet, Raises Target to $165
Barclays maintained its Equal-Weight rating on Insulet and raised its price target to $165 per share from $150.
Barclays maintained its Equal-Weight rating on Insulet and raised its price target to $165 per share from $150.